Table 5.

Cons and pros granulocyte colony-stimulating factor therapy in patients with Duchenne muscular dystrophy.

Pros	Cons
Long-term study	Open-label study—no control group
Objective functional testes	Small number of study group
Qualification patients with different types of dystrophy and at every age	Not a homogeneous group of study subjects
Lack of disqualification because the type of genome mutation	Different functional states of patients (independent or wheelchair dependent)
Well-tolerated therapy	Patients with or without steroids therapy